JPSE - ETF AI Analysis
Top Page
JPMorgan Diversified Return U.S. Small Cap Equity ETF (JPSE)
Rating:67Neutral
Price Target:―
Positive Factors
Strong Recent Performance
The fund’s year-to-date and multi-month returns have been strong, suggesting solid recent momentum in its strategy.
Well-Performing Top Holdings
Many of the largest positions have delivered strong gains so far this year, helping support the ETF’s overall performance.
Broad Sector Diversification
The ETF spreads its investments across many different sectors, which can help reduce the impact if any single industry struggles.
Negative Factors
Heavy U.S. Focus
Almost all of the fund’s assets are invested in U.S. companies, offering very limited geographic diversification.
Small-Cap Company Risk
Because the ETF focuses on smaller companies, it may be more volatile and sensitive to market downturns than large-cap funds.
Moderate Expense Ratio
The fund’s fees are not extremely high but are meaningful enough that they slightly reduce the net return investors receive.
JPSE vs. SPDR S&P 500 ETF (SPY)
AUM609.10M
RegionNorth America
Expense Ratio0.29%
Beta0.87
IssuerJPMorgan
Inception DateNov 15, 2016
Dividend Yield1.29%
Asset ClassEquity
Index TrackedJPMorgan Diversified Factor US Small Cap Equity Index
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume11,810
30 Day Avg. Volume24,873
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
71.14Price Target Upside― Downside
Rating ConsensusModerate Buy
Number of Analyst Covering554
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
JPSE Summary
JPSE is an exchange-traded fund that follows the JPMorgan Diversified Factor US Small Cap Equity Index, focusing on smaller U.S. companies across many industries like real estate, technology, health care, and energy. It holds a wide mix of stocks, including names like Compass and Clear Secure, giving investors broad exposure to the small‑cap part of the market. Someone might invest in JPSE to seek long‑term growth and add diversification beyond large, well-known companies. A key risk is that small‑cap stocks can be more volatile, so the fund’s value can go up and down more sharply with the market.
How much will it cost me?The expense ratio for the JPMorgan Diversified Return U.S. Small Cap Equity ETF (JPSE) is 0.29%, which means you’ll pay $2.90 per year for every $1,000 invested. This is slightly higher than average for ETFs because it is actively managed, aiming to select and balance small-cap stocks strategically to optimize returns and manage risks.
What would affect this ETF?The JPSE ETF, focused on U.S. small-cap stocks, could benefit from economic growth and innovation in sectors like technology and healthcare, which are among its top exposures. However, it may face challenges from rising interest rates, which can increase borrowing costs for smaller companies, and economic slowdowns that typically impact small-cap stocks more than larger firms. Additionally, sector-specific risks, such as regulatory changes in energy or materials, could influence performance.
JPSE Top 10 Holdings
JPSE leans into U.S. small caps with a noticeable tilt toward real estate and niche financial and health care names. Recent strength from Par Pacific in energy and Protagonist Therapeutics in biotech has helped power the fund, while snack maker Utz adds a steady, consumer-focused engine. Real estate plays like LXP Industrial Trust and CareTrust REIT have been quietly rising, giving the portfolio a more defensive backbone. Compass, tied to the housing market, has been more mixed, occasionally losing steam and dampening some of the fund’s momentum.
Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| Protagonist Therapeutics | 0.40% | $2.45M | $9.44B | 179.07% | 68 Neutral | |
| Enova International | 0.40% | $2.44M | $6.29B | 142.21% | 71 Outperform | |
| Compass | 0.40% | $2.41M | $9.66B | 49.76% | 61 Neutral | |
| UTZ Brands | 0.39% | $2.37M | $2.03B | 13.15% | 56 Neutral | |
| IMPINJ | 0.39% | $2.36M | $5.60B | 14.78% | 56 Neutral | |
| The Chefs' Warehouse | 0.37% | $2.21M | $4.50B | 74.69% | 72 Outperform | |
| 10x Genomics | 0.37% | $2.21M | $6.61B | 375.79% | 60 Neutral | |
| Digi International | 0.36% | $2.16M | $3.10B | 154.62% | 77 Outperform | |
| Materion | 0.36% | $2.15M | $6.04B | 163.84% | 69 Neutral | |
| Interface | 0.35% | $2.14M | $2.22B | 50.50% | 72 Outperform |
JPSE Technical Analysis
Positive
―
Price Trends
59.51
Positive
57.74
Positive
54.67
Positive
Market Momentum
0.43
Negative
63.52
Neutral
88.79
Negative
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For JPSE, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 60.03, equal to the 50-day MA of 59.51, and equal to the 200-day MA of 54.67, indicating a bullish trend. The MACD of 0.43 indicates Negative momentum. The RSI at 63.52 is Neutral, neither overbought nor oversold. The STOCH value of 88.79 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JPSE.
JPSE Peer Comparison
Comparison Results
Performance Comparison
JPSE
JPMorgan Diversified Return U.S. Small Cap Equity ETF
61.27
14.13
29.97%
OUSM
OShares U.S. Small-Cap Quality Dividend ETF
―
―
―
JHSC
John Hancock Multifactor Small Cap ETF
―
―
―
EES
WisdomTree U.S. SmallCap Fund
―
―
―
BBSC
JPMorgan BetaBuilders U.S. Small Cap Equity ETF
―
―
―
SFLO
VictoryShares Small Cap Free Cash Flow ETF
―
―
―
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
DisclaimerThis AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents